The headline result was a mean 17.5% body-weight reduction at 24 weeks in the 12 mg arm, with clear dose-response behavior across the four active doses
Patients considering GLP-1 receptor agonist or dual GIP/GLP-1 therapy should understand that these medications facilitate weight loss through appetite reduction and decreased food intake, not by "speeding up metabolism" or burning additional calories at rest
The NHS and NICE do not recommend peptides for ED, instead advocating proven treatments like PDE5 inhibitors (sildenafil, tadalafil)
They are attributed to anti-inflammatory, antioxidant, and antihypertensive properties and regulate the abnormal expression of some genes in polycystic ovary syndrome
Lucky for you, were here to break down the difference between the two and help you figure out which one deserves a spot on your bathroom shelf
Weiler M., University of Heidelberg, Department of Neurology